WASHINGTON — Doctors may soon get a new way to clear blocked neck arteries: a stent that comes with a tiny filter to catch clots stirred up by the procedure before they float to the brain.
Don't miss these Health stories
More women opting for preventive mastectomy - but should they be?
Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.
- Larry Page's damaged vocal cords: Treatment comes with trade-offs
- Report questioning salt guidelines riles heart experts
- CDC: 2012 was deadliest year for West Nile in US
- What stresses moms most? Themselves, survey says
- More women opting for preventive mastectomy - but should they be?
At issue is a way to prevent pending strokes by treating blockages in the carotid artery, the main blood vessel leading to the brain.
Currently, the main method is an operation called a carotid endarterectomy, where surgeons cut into the artery and remove clogs. It requires general anesthesia, making it too risky for some people — and sometimes the operation itself triggers strokes by loosening particles that lodge in the brain. Up to 200,000 Americans a year undergo this procedure.
A less invasive alternative is called angioplasty — sending a tiny balloon into the artery to push clogs out of the way, and then propping the artery open with a scaffolding-like device called a stent.
The new twist: Cordis Corp. developed a tiny filter to go with its stent and catch any stirred-up debris — in hopes of lowering the risk of an angioplasty-triggered stroke. Doctors would put the net-like filter in first, do the angioplasty, insert the stent, and then drag out the filter.
How strokes happenCordis cited a study that found 12 percent of patients getting the filtered-stent procedure had suffered a stroke, heart attack or died a year after the procedure — compared with 19 percent of patients who underwent the standard carotid surgery.
Wednesday, the FDA’s scientific advisers cautiously recommended approval of Cordis’ Precise stent-plus-Angioguard system. But they stressed that it should be used only in high-risk patients, and that the stent should be used with the filter.
The FDA isn’t bound by its advisers’ recommendations but usually follows them.
© 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.